山东医药
山東醫藥
산동의약
Shandong Medical Journal
2015年
40期
1-3,109
,共4页
潘威%孙倩%李舒展%张喜英%曹水%任秀宝
潘威%孫倩%李舒展%張喜英%曹水%任秀寶
반위%손천%리서전%장희영%조수%임수보
癌,非小细胞肺%磷酸甘油酸变位酶1%实时荧光定量PCR%预后%生存分析
癌,非小細胞肺%燐痠甘油痠變位酶1%實時熒光定量PCR%預後%生存分析
암,비소세포폐%린산감유산변위매1%실시형광정량PCR%예후%생존분석
carcinoma,non-small-cell lung%phosphoglycerate mutase 1%real-time fluorescent quantitative PCR%prognosis%survival analysis
目的:探讨非小细胞肺癌(NSCLC)组织中磷酸甘油酸变位酶1(PGAM1)的表达及其与患者预后的关系。方法选择NSCLC患者206例,采用Real-time PCR技术检测其肿瘤组织中PGAM1 mRNA表达,其中28例患者配对检测其癌旁正常组织中PGAM1 mRNA表达。以ROC曲线中约登指数最高值(1.96)作为PGAM1 mRNA表达水平的分割点,>1.96为PGAM1 mRNA高表达,≤1.96为PGAM1 mRNA低表达。分析NSCLC组织中不同PGAM1 mRNA表达与患者临床病理特征的关系;采用Kaplan-Meier生存分析法计算不同PGAM1 mRNA表达者的总生存期( OS)、无病生存期( DFS),并采用Cox比例风险回归模型分析患者OS、DFS的影响因素。结果28例NSCLC患者癌组织中PGAM1 mRNA表达明显高于其癌旁正常组织(P<0.05)。 PGAM1 mRNA表达与NSCLC患者吸烟状况、组织学类型、病理学T分级有关(P均<0.05)。 Kaplan-Meier生存分析显示,PGAM1 mRNA高表达者OS、DFS中位时间均低于PGAM1 mRNA低表达者(P均<0.01)。 Cox比例风险回归模型分析显示,PGAM1 mRNA高表达是OS、DFS的独立影响因素(HR分别为1.730、1.698,P均<0.05)。结论 PGAM1 mRNA在NSCLC组织中表达升高,其高表达提示患者预后不良。
目的:探討非小細胞肺癌(NSCLC)組織中燐痠甘油痠變位酶1(PGAM1)的錶達及其與患者預後的關繫。方法選擇NSCLC患者206例,採用Real-time PCR技術檢測其腫瘤組織中PGAM1 mRNA錶達,其中28例患者配對檢測其癌徬正常組織中PGAM1 mRNA錶達。以ROC麯線中約登指數最高值(1.96)作為PGAM1 mRNA錶達水平的分割點,>1.96為PGAM1 mRNA高錶達,≤1.96為PGAM1 mRNA低錶達。分析NSCLC組織中不同PGAM1 mRNA錶達與患者臨床病理特徵的關繫;採用Kaplan-Meier生存分析法計算不同PGAM1 mRNA錶達者的總生存期( OS)、無病生存期( DFS),併採用Cox比例風險迴歸模型分析患者OS、DFS的影響因素。結果28例NSCLC患者癌組織中PGAM1 mRNA錶達明顯高于其癌徬正常組織(P<0.05)。 PGAM1 mRNA錶達與NSCLC患者吸煙狀況、組織學類型、病理學T分級有關(P均<0.05)。 Kaplan-Meier生存分析顯示,PGAM1 mRNA高錶達者OS、DFS中位時間均低于PGAM1 mRNA低錶達者(P均<0.01)。 Cox比例風險迴歸模型分析顯示,PGAM1 mRNA高錶達是OS、DFS的獨立影響因素(HR分彆為1.730、1.698,P均<0.05)。結論 PGAM1 mRNA在NSCLC組織中錶達升高,其高錶達提示患者預後不良。
목적:탐토비소세포폐암(NSCLC)조직중린산감유산변위매1(PGAM1)적표체급기여환자예후적관계。방법선택NSCLC환자206례,채용Real-time PCR기술검측기종류조직중PGAM1 mRNA표체,기중28례환자배대검측기암방정상조직중PGAM1 mRNA표체。이ROC곡선중약등지수최고치(1.96)작위PGAM1 mRNA표체수평적분할점,>1.96위PGAM1 mRNA고표체,≤1.96위PGAM1 mRNA저표체。분석NSCLC조직중불동PGAM1 mRNA표체여환자림상병리특정적관계;채용Kaplan-Meier생존분석법계산불동PGAM1 mRNA표체자적총생존기( OS)、무병생존기( DFS),병채용Cox비례풍험회귀모형분석환자OS、DFS적영향인소。결과28례NSCLC환자암조직중PGAM1 mRNA표체명현고우기암방정상조직(P<0.05)。 PGAM1 mRNA표체여NSCLC환자흡연상황、조직학류형、병이학T분급유관(P균<0.05)。 Kaplan-Meier생존분석현시,PGAM1 mRNA고표체자OS、DFS중위시간균저우PGAM1 mRNA저표체자(P균<0.01)。 Cox비례풍험회귀모형분석현시,PGAM1 mRNA고표체시OS、DFS적독립영향인소(HR분별위1.730、1.698,P균<0.05)。결론 PGAM1 mRNA재NSCLC조직중표체승고,기고표체제시환자예후불량。
Objective To investigate the expression of phosphoglycerate mutase 1 ( PGAM1 ) in patients with non-small-cell lung cancer ( NSCLC) and its correlation with the prognosis.Methods We measured PGAM1 mRNA expression level in the tumor tissues of 206 cases of NSCLC patients by real-time PCR, of which 28 patients were detected the PGAM1 mRNA expression in the matched adjacent normal tissues.We defined the expression of PGAM1 mRNA>1.96 as the high expression group, PGAM1 mRNA≤1.96 as the low expression group, the correlations of PGAM1 mRNA expression in NSCLC tumor tissues with clinicopathologic characeristics were analyzed.Kaplan-Meier survival analysis was used to evaluate the overall survival ( OS) and disease-free survival ( DFS) of PGAM1 mRNA in the high expression group and low expression group.And the Cox regression models were used to analyze the risk factors influencing the patients′OS and DFS.Results The PGAM1 mRNA expression was significantly higher in 28 cases of NSCLC tumor tissues than their matched normal tissues (P<0.05).The PGAM1 mRNA expression was related with smoking, histological type and advanced T stage (all P<0.05).Kaplan-Meier analysis revealed the median time of OS and DFS in PGAM1 mRNA high expression group was lower than that of PGAM1 mRNA low expression group (all P<0.01).Cox regression analysis indicated that PGAM1 mRNA was an independent risk factor for OS (HR=1.730, P<0.05) and DFS (HR=1.698, P<0.05).Conclusion The expression of PGAM1 mRNA in NSCLC tissues was increased, and its high expression indicates their poor prognosis.